Skip to main navigation
  • About Us
    • Our Story
    • Leadership
    • Board of Directors
  • Pipeline
    • Development Pipeline
    • BH-30643
    • BH-30236
    • BH-501284
    • Scientific Approach
    • Posters & Presentations
  • Patients
    • Clinical Trials
    • Expanded Access
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Governance
      • Documents, Charters & Committees
      • Management Team
      • Board of Directors
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Careers
    • Open Positions
  • Contact
  • MenuMenu

SEC Filing Details

  • Overview
  • Press Releases
  • Events & Presentations
  • Governance
    • Documents, Charters & Committees
    • Management Team
    • Board of Directors
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

Document Details

Form
8-K
Filing Date
Aug 10, 2026
Document Date
Aug 10, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
BlossomHill Therapeutics, Inc.
Issuer
BLOSSOMHILL THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
  • Terms of Service
  • Privacy Policy
  • Cookie Policy

© 2026 BlossomHill Therapeutics, Inc.

TwitterTwitterLinkedInLinkedIn
Scroll to top Scroll to top Scroll to top